These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 163628)

  • 1. Histocompatibility antigens and solid malignant neoplasms.
    Tarpley JL; Chretien PB; Rogentine GN; Twomey PL; Dellon AL
    Arch Surg; 1975 Mar; 110(3):269-71. PubMed ID: 163628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of immune reactivity and clinical status in cancer.
    Chretien PB; Catalona WJ; Twomey PL; Sample WF
    Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative dinitrochlorobenzene contact sensitivity in preoperative and cured cancer patients.
    Chretien PB; Twomey PL; Trahan EE; Catalona WJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():263-6. PubMed ID: 4787068
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Cellular immunity in cured cancer patients.
    Twomey PL; Catalona WJ; Chretien PB
    Cancer; 1974 Feb; 33(2):435-40. PubMed ID: 4812762
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered expression of human monocyte Fc receptors in malignant disease.
    Rhodes J
    Nature; 1977 Jan; 265(5591):253-5. PubMed ID: 189209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of a common cancer antigen in several human tumors of different location].
    Rogal'skiĭ VIa
    Biull Eksp Biol Med; 1967 Mar; 63(3):110-2. PubMed ID: 4988279
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
    Morton DL; Eilber FR; Malmgren RA
    Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ; Chretien PB
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients.
    Chretien PB; Crowder WL; Gertner HR; Sample WF; Catalona WJ
    Surg Gynecol Obstet; 1973 Mar; 136(3):380-4. PubMed ID: 4688801
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 12. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 13. HL-A antigens of human tumor-derived cell lines and viral transformed fibroblasts in culture.
    Kersey JH; Yunis EJ; Todaro GJ; Aaronson SA
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):453-6. PubMed ID: 4350786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.
    Catalona WJ; Sample WF; Chretien PB
    Cancer; 1973 Jan; 31(1):65-71. PubMed ID: 4683045
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for fetal antigen in human sarcoma.
    Mukherji B; Hirshaut Y
    Science; 1973 Aug; 181(4098):440-2. PubMed ID: 4577921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
    Fiorella R; Di Nicola V; Giannubilo C; Facondo M
    Acta Otorhinolaryngol Ital; 1988; 8(2):133-6. PubMed ID: 3188902
    [No Abstract]   [Full Text] [Related]  

  • 19. A search for common tumor specific antigen and serum blocking factor in head and neck epidermoid carcinomas.
    Kennedy JT
    Laryngoscope; 1975 May; 85(5):806-22. PubMed ID: 49834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.